content top

Long-term Outcomes of Human Embryonic Stem Cell Derived Retinal Pigment Epithelial Cell Transplantation for Retinal Degeneration from Two Phase I/II Trials

Long-term Outcomes of Human Embryonic Stem Cell Derived Retinal Pigment Epithelial Cell Transplantation for Retinal Degeneration from Two Phase I/II Trials ABSTRACT Purpose: To summarize long-term safety data and clinical outcomes of two prospective phase I/II studies assessing safety and tolerability of human Embryonic Stem Cell (hESC) derived retinal pigment epithelial (MA09-hRPE) cell transplantation in patients with atrophic...

Read More

Use of 25-gauge Pars Plana Vitrectomy Surgery for Primary Repair of Rhegmatogenous Retinal Detachments

http://www.evrs.eu/medias/2006/congress/Use-of-25-gauge-Pars-Plana-Vitrectomy-Surgery-for-Primary-Repair-of-Rhegmatogenous-Retinal-Detachments.swf Amitabh K. Bharadwaj, MD, MSc (Philadelphia, PA), Mariah A. Schumacher, BA (Philadelphia, PA), Michael A. Samuel, MD (Blue Bell, PA), Robert C. Kleiner, MD (North Wales, PA), Carl D. Regillo, MD, FACS (Philadelphia, PA), Carl H. Park, MD (Philadelphia, PA), J. Arch McNamara, MD, FRCS(C)...

Read More

Vision-specific Quality of Life at 12 Months in Subjects with or without Classic CNV Due to AMD: Phase III Clinical Trial of Ranibizumab (Lucentis)

Carl D. Regillo, MD, FACS (Philadelphia, PA),* Neil M. Bressler, MD (Baltimore, MD),* Jennifer T. Fine, PhD (South San Francisco, CA),* Chantal M. Dolan, PhD (South San Francisco, CA),* Claudine Marceau, PhD (Basel, Switzerland),* Tom S. Chang, MD (Pasadena, CA)* PURPOSE: To examine the effects of less frequent dosing of ranibizumab (LucentisTM) on patientreported visionspecific QoL through 12 months using the NEI-VFQ 25 in PIER, a phase...

Read More

25 Gauge Vitrectomy: Outcomes and Complications

http://www.evrs.eu/medias/2006/congress/25-Gauge-Vitrectomy:-Outcomes-and-Complications.swf Carl D. Regillo, MD, FACS (Philadelphia, PA),* Omesh Gupta, MD (Philadelphia, PA), Allen C. Ho, MD (Wyndmoor, PA), Richard S. Kaiser, MD (Wyndmoor, PA), Mitchell S. Fineman, MD (Cherry Hill, NJ), James F. Vander, MD (Wyndmoor, PA), J. Arch McNamara, MD, FRCS(C) (Wyndmoor, PA) PURPOSE: To report surgical outcomes and both intraand postoperative...

Read More

Increased Visual Acuity in Fellow Affected Eyes of Subjects Undergoing Therapy with Intravenous EvizonTM (Squalamine Lactate) for Exudative AMD

http://www.evrs.eu/medias/2006/congress/Increased-Visual-Acuity-in-Fellow-Affected-Eyes-of-Subjects-Undergoing-Therapy-with-Intravenous-EvizonTM-(Squalamine-Lactate)-for-Exudative-AMD.swf Michael J. Gast, MD, PhD (Plymouth Meeting, PA),* Carl D. Regillo, MD, FACS (Philadelphia, PA), Edgar L. Thomas, MD (Beverly Hills, CA), Charles A. Garcia, MD (Houston, TX), Roger Vogel, MD (Tampa, FL)* PURPOSE: High percentages of patients with wet AMD...

Read More
content top